Thyroid nodules: how to assess the risk of malignancy?

被引：0
|
作者：
Cao, C. Do [1 ]
Ladsous, M. [1 ,2 ]
机构：
[1] CHRU Lille, Hop Claude Huriez, Serv Endocrinol, Lille, France
[2] Ctr Hosp Valenciennes, Serv Endocrinol, Valenciennes, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2019年 / 23卷 / 4-5期
关键词：
Thyroid nodule; Thyroid ultrasound; Thyroid cytology; Indeterminate cytology; Molecular markers; ASSOCIATION GUIDELINES; MANAGEMENT; SYSTEM;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
About 90 to 95% of thyroid nodules are benign and will required a basic follow-up. Ultrasound evaluation and cytological analysis for selected nodules, with formal reports made according to respective EU-TIRADS (European -Thyroid Imaging Reporting and Data System) classification and Bethesda system, can provide a quantification of malignancy risk and allow to adjust clinical and sonographic monitoring and to elaborate surgical treatment. In case of non-diagnostic (Bethesda 1) or indeterminate (Bethesda III and IV) cytologie one has to discuss reassessment and follow-up, and second line tools like elastography, scintiscan imaging and cytological molecular markers, if cost-effective.
引用
下载
收藏
页码：110 / 115
页数：6
相关论文
共 50 条
  • [31] TSH and thyroglobulin Antibodies association with risk of malignancy of thyroid nodules
    Chehboun, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S630 - S630
  • [32] Subtype of atypia on cytology and risk of malignancy in pediatric thyroid nodules
    Cherella, Christine E.
    Hollowell, Monica L.
    Smith, Jessica R.
    Zendejas, Benjamin
    Modi, Biren P.
    Cibas, Edmund S.
    Wassner, Ari J.
    CANCER CYTOPATHOLOGY, 2022, 130 (05) : 330 - 335
  • [33] Risk for malignancy of thyroid nodules based on ultrasound imaging characteristics
    Wu, Qi
    Li, Juanjuan
    Wu, Juan
    Li, Xiang
    Chen, Chuang
    Jiang, Nan
    Sun, Shengrong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11817 - 11823
  • [34] Risk of malignancy for each Bethesda class in pediatric thyroid nodules
    Norlen, Olov
    Charlton, Amanda
    Sarkis, Leba M.
    Henwood, Tony
    Shun, Albert
    Gill, Anthony J.
    Delbridge, Leigh
    JOURNAL OF PEDIATRIC SURGERY, 2015, 50 (07) : 1147 - 1149
  • [35] Serum TSH is not a risk factor for malignancy of pediatric thyroid nodules
    Wang, Guoliang
    Ren, Na
    Wang, Shengcai
    Zhang, Xuexi
    Li, Yanzhen
    Sun, Nian
    Liu, Qiaoyin
    Zhang, Jie
    Song, Wenqi
    Ni, Xin
    ENDOCRINE-RELATED CANCER, 2021, 28 (04) : 247 - 255
  • [36] Evaluation of the Malignancy Risk in Nodules Expanding the Thyroid Gland Capsule
    Arslan, Ismail Emre
    Bostan, Hayri
    Hepsen, Sema
    Akhanli, Pinar
    Sencar, Muhammed Erkam
    Cakal, Erman
    HORMONE AND METABOLIC RESEARCH, 2024,
  • [37] HOT NODULES AND THYROID MALIGNANCY
    GRIFFITHS, AP
    TINDALL, H
    NUCLEAR MEDICINE COMMUNICATIONS, 1987, 8 (12) : 1088 - 1089
  • [38] Pediatric Thyroid Nodules and Malignancy
    Jatana, Kris R.
    Zimmerman, Donald
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2015, 48 (01) : 47 - +
  • [39] Thyroid cytology and the risk of malignancy in thyroid nodules: Importance of nuclear atypia in indeterminate specimens
    Kelman, AS
    Rathan, A
    Leibowitz, J
    Burstein, DE
    Haber, RS
    THYROID, 2001, 11 (03) : 271 - 277
  • [40] Do thyroid nodules that arise in the isthmus have a higher risk of malignancy?
    Pastorello, Ricardo
    Valerio, Ediel
    Lobo, Alberto
    Maia, Antonio
    Saieg, Mauro
    CANCER CYTOPATHOLOGY, 2020, 128 (08) : 520 - 522
12345